Taxane-induced peripheral neuropathy has good long-term prognosis: A 1- to 13-year evaluation

Journal of Neurology

Volumn 259, Issue 9, 2012, Pages 1936-1943

  Osmani, Karima ^a   Vignes, Stéphane ^b   Aissi, Mouna ^a   Wade, Fatou ^a   Milani, Paolo ^a,c   Lévy, Bernard I ^a,c   Kubis, Nathalie ^a,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Hopital de la Fondation Cognacq Jay   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Chemotherapy; Docetexel; Paclitaxel; Peripheral neuropathy; Taxanes

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; PACLITAXEL;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; ELECTROMYOGRAPHY; ELECTRONEUROMYOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; OVARY CANCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; SENSORY NEUROPATHY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; PACLITAXEL; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; TAXOIDS; TIME FACTORS;

EID: 84867336561     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6442-5     Document Type: Article

References (16)

1. Roglio I, Bianchi R, Camozzi F, Carozzi V, Cervellini I, Crippa D, Lauria G, Cavaletti G, Melcangi RC (2009) Docetaxelinduced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model. J Periph Nerv Syst 14:36-44
2. Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, Einzig AI, Wiernik P, Schaumburg HHl (1989) Taxol produces a predominantly sensory neuropathy. Neurology 39:368-373
3. Park SB, Lin CS, Krishnan AV, Kiernan MC, Friedlander ML, Lewis CR, Kiernan MC (2011) Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle Nerve 43:367-374
4. Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E, Laufman L, Sundaram S, Urba WJ, Pritchard KI, Mennel R, Richards D, Olsen S, Meyers ML, Ravdin PM (2005) Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 22:5542-5551
5. Sarosy AG, Hussain MM, Seiden MV, Fuller AF, Nikrui N, Goodman A, Minasian L, Reed E, Steinberg SM, Kohn EC (2010) Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-Prognosis, advanced-stage epithelial ovarian cancer. Cancer 116:1476-1484
6. New PZ, Jackson CE, Rinaldi D, Burris H, Barohn RJ (1996) Peripheral neuropathy secondary to docetaxel (Taxotere). Neurology 46:108-111
7. Hilkens PH, Verweij J, Stoter G, Vecht CJ, Van Putten WL, Van den Bent MJ (1996) Peripheral neurotoxicity induced by docetaxel. Neurology 46:104-108
8. Argyriou AA, Polychronopoulos P, Koutras A, Xiros N, Petsas T, Argyriou K, Kalofonos HP, Chroni E (2007) Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel. Eur J Cancer Care 16:231-237
9. Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20:1-15
10. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR (1994) Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35:304-311
11. Lee JJ, Swain SM (2006) Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents. J Clin Oncol 24:1633-1642
12. Hilkens PH, Pronk LC, Verweij J, Vecht CJ, van Putten WL, van den Bent MJ (1997) Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin. Br J Cancer 75:417-422
13. Martino MA, Miller E, Grendys EC Jr (2005) The administration of chemotherapy in a patient with Charcot-Marie-Tooth and ovarian cancer. Gynecol Oncol 97:710-712
14. Vignes S, Lebrun-Vignes B (2007) Sclerodermiform aspect of arm lymphoedema after treatment with docetaxel for breast cancer. J Eur Acad Dermatol Venereol 21:1131-1133
15. Nahleh Z, Pruemer J, Lafollette J, Sweany S (2010) Melatonin, a promising role in taxane-related neuropathy. Clinical Medicine Insights: Oncology 4:35-41
16. Hilkens PH, Verweij J, Vecht CJ, Stoter G, Van den Bent MJ (1997) Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere). Ann Oncol 8:187-190